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Abstract Pancreatic islet β-cell insufficiency underlies pathogenesis of diabetes mellitus; thus, 
functional β-cell replacement from renewable sources is the focus of intensive worldwide effort. 
However, in vitro production of progeny that secrete insulin in response to physiological cues from 
primary human cells has proven elusive. Here we describe fractionation, expansion and conversion 
of primary adult human pancreatic ductal cells into progeny resembling native β-cells. FACS-sorted 
adult human ductal cells clonally expanded as spheres in culture, while retaining ductal 
characteristics. Expression of the cardinal islet developmental regulators Neurog3, MafA, Pdx1 and 
Pax6 converted exocrine duct cells into endocrine progeny with hallmark β-cell properties, including 
the ability to synthesize, process and store insulin, and secrete it in response to glucose or other 
depolarizing stimuli. These studies provide evidence that genetic reprogramming of expandable 
human pancreatic cells with defined factors may serve as a general strategy for islet replacement in 
diabetes.
DOI: 10.7554/eLife.00940.001
Introduction
The pancreas is a vital organ with exocrine and endocrine cell functions, and a root of lethal human 
diseases including diabetes mellitus, pancreatitis, and pancreatic ductal adenocarcinoma. Exocrine 
acinar cells produce digestive zymogens that are delivered to the intestines by a branching network of 
exocrine ductal cells that secrete bicarbonate and other products. Pancreatic endocrine functions 
derive from clusters of epithelial cells (islets of Langerhans) called α-, β-, δ-, and PP-cells that respec-
tively synthesize, store, and secrete the hormones Glucagon, Insulin, Somatostatin, and Pancreatic 
polypeptide (Benitez et al., 2012). Insulin production by islet β-cells is highly regulated: key features 
of mature β-cells include preproinsulin (INS) transcription, proinsulin processing by endo- and exo-
peptidases and storage of the proinsulin cleavage products insulin and C-peptide in dense core 
vesicles. Likewise, cardinal β-cell functions regulate insulin release in response to glucose and other 
secretagogues, including glucose sensing and metabolism through the enzyme glucokinase, and use 
of ATP-dependent potassium channels (KATP) and voltage-gated calcium channels to induce insulin 
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exocytosis (reviewed in Suckale and Solimena, 2010). Deficiency or malfunctioning of β-cells produces 
impaired glucose regulation and diabetes mellitus, a disease with autoimmune (type 1, T1DM) and 
pandemic forms (type 2; Ashcroft and Rorsman, 2012). Thus, replacement or regeneration of functional 
human β-cells is an intensely-sought goal.
Human islet transplantation can be used to replace β-cell function in T1DM (reviewed in Vardanyan 
et al., 2010), but a shortage of donors currently precludes broad use of human pancreatic islets for 
β-cell replacement. Because of their expandability and multipotency, human embryonic stem cells 
(hESCs) and induced pluripotent stem cells (iPSCs) have been explored as sources of replacement 
insulin-producing cells (reviewed in Hebrok, 2012). However, directing the differentiation of these 
developmentally ‘primitive’ cells through multiple sequential fates into β-cell-like progeny that 
synthesize, process, store, and secrete insulin while lacking tumorigenic potential has challenged 
investigators worldwide (Fujikawa et al., 2005; McKnight et al., 2010; Cheng et al., 2012). Moreover, 
different hESC and iPSC cell lines exhibit significant variability during development into insulin-
producing cells (Nostro and Keller, 2012). Recent work demonstrated that differentiated cell types in 
adult organs, including the mouse pancreas, can be experimentally ‘reprogrammed’ into progeny 
resembling islet cells, suggesting a new strategy for β-cell replacement (Vierbuchen and Wernig, 
2011). For example, adult mouse pancreatic acinar cells can be converted into insulin-producing cells 
in vitro and in vivo (Minami et al., 2005; Zhou et al., 2008). However, little progress has been made 
in reprogramming primary human epithelial cells into different cell types, including conversion of 
pancreatic non-β-cells toward a human β-cell fate (Vierbuchen and Wernig, 2011). Thus, systems 
permitting expansion and genetic modulation of human pancreatic cells could powerfully influence 
studies of β-cell biology and replacement.
Pancreatic ducts constitute 30–40% of human pancreas and have been proposed as a potential 
source of replacement β-cells (Bouwens and Pipeleers, 1998; Bonner-Weir et al., 2004). During 
pancreas development, fetal endocrine cells derive from primitive ductal epithelium (reviewed by Pan 
and Wright, 2011; Pictet and Rutter, 1972). In addition, some studies have suggested that in adult 
mice, β-cells may be produced from pancreatic ductal epithelium (Inada et al., 2008; Xu et al., 2008; 
Rovira et al., 2010). However, recent lineage tracing evidences have not supported this view 
(Solar et al., 2009; Furuyama et al., 2011; Kopp et al., 2011). In humans, prior studies have sug-
gested that adult human primary ductal cells in heterogeneous cell mixtures may harbor the potential 
eLife digest Diabetes mellitus is a disease that can lead to dangerously high blood sugar levels, 
causing numerous complications such as heart disease, glaucoma, skin disorders, kidney disease, 
and nerve damage. In healthy individuals, beta cells in the pancreas produce a hormone called 
insulin, which stimulates cells in the liver, muscles and fat to take up glucose from the blood. 
However, this process is disrupted in people with diabetes, who either have too few pancreatic beta 
cells (type 1 diabetes) or do not respond appropriately to insulin (type 2 diabetes).
All patients with type 1 diabetes, and some with type 2, must inject themselves regularly with 
insulin, but this does not always fully control the disease. Some type 1 patients have been 
successfully treated with beta cells transplanted from deceased donors, but there are not enough 
donor organs available for this to become routine. Thus, intensive efforts worldwide are focused on 
generating insulin-producing cells in the lab from human stem cells. However, the cells produced in 
this way can give rise to tumors.
Now, Lee et al. have shown that duct cells, which make up about 30% of the human pancreas, 
can be converted into cells capable of producing and secreting insulin. Ductal cells obtained from 
donor pancreases were first separated from the remaining tissue and grown in cell culture. Viruses 
were then used to introduce genes that reprogrammed the ductal cells so that they acquired the 
ability to make, process and store insulin, and to release it in response to glucose—hallmark 
features of functional beta cells.
As well as providing a potential source of cells for use in transplant or cell conversion therapies for 
diabetes, the ability to grow and maintain human pancreatic ductal cells in culture may make it easier to 
study other diseases that affect the pancreas, including pancreatitis, cystic fibrosis, and adenocarcinoma.
DOI: 10.7554/eLife.00940.002
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to generate endocrine-like progeny (Bonner-Weir et al., 2000; Heremans et al., 2002; Swales et al., 
2012), but interpretation in these studies was limited by the probability of islet cell contamination. 
Therefore, the potential for conversion of pancreatic ductal cells toward an endocrine fate remains 
unclear. Moreover, prior studies have revealed only limited proliferative capacity of primary human 
pancreatic ductal cells in culture (Rescan et al., 2005). Thus, despite their relative abundance, multiple 
practical issues have prevented development of human pancreatic ductal cells as a source of replace-
ment β-cells.
Here we report that normal human adult pancreatic duct cells can be sorted, clonally expanded, 
and genetically converted into endocrine cells. Human insulin-producing cells (IPCs) produced from 
sorted duct cells exhibited hallmark features of functional neonatal β-cells including high-level 
preproinsulin (INS) expression, proinsulin processing and dense-core granule formation. Moreover, 
secretion of insulin and insulin C-peptide from IPCs is stimulated by glucose and KATP channel stimu-
lants in a calcium-dependent manner. Together these studies reveal a new system for investigating 
human pancreatic duct cell biology, genetics, and β-cell regeneration.
Results
Purification and expansion of primary CD133+ human pancreatic 
ductal cells
To identify human pancreatic epithelial cells that can be grown and maintained in culture, we system-
atically screened cell isolation methods and culture conditions with dispersed adult human pancreatic 
cells obtained from cadaveric donors without known pancreatic cancer, diabetes mellitus, or other 
pancreatic diseases (Table 1). With primary cells plated at low density, we observed formation of 
multicellular epithelial spheres, when cultured in Matrigel with a serum-free culture medium without 
feeder cells (‘Materials and methods’, Figure 1—figure supplement 1A). The multicellular sphere 
formation suggested primary cell expansion, so based on this assay we fractionated cells by fluorescence-
activated cell sorting (FACS) to isolate and characterize sphere-forming pancreatic cells. A survey of 
cell surface markers used for fetal mouse pancreatic cell isolation (Sugiyama et al., 2007) revealed 
that antibodies recognizing CD133 enriched sphere-forming cells by four fold, whereas sphere-forming 
cells were depleted in the CD133neg fraction (Figure 1A,B). Immunohistochemical analysis of the 
human adult pancreas revealed CD133 expression at the apical portion of duct epithelial cells that 
co-expressed keratin 19 (KRT19), whereas CD133 was undetectable in islet endocrine cells or acinar 
cells (Figure 1C, Figure 1—figure supplement 1B), consistent with prior reports (Lardon et al., 2008). 
We have achieved sphere formation from over 35 consecutive adult donors (Table 1); thus, the sphere 
formation of primary adult human pancreatic CD133+ cells was highly reproducible.
To assess the properties of FACS-purified adult pancreatic CD133+ cells, we performed quantitative 
reverse transcription PCR (qRT-PCR). This revealed that CD133+ cells expressed high levels of mRNA 
encoding ductal markers (KRT19 and CAR2), while mRNAs expressed in acinar (CPA1 and CEL) and 
endocrine (CHGA, INS, and GCG) cells were exclusively enriched in the CD133neg fraction (Figure 1D, 
Figure 1—figure supplement 1C). Immunostaining confirmed that >98% of sorted CD133+ cells 
produced KRT19, whereas CD133+ cells produced no detectable islet hormone (Figure 1E,F, 
Figure 1—figure supplement 1D). Thus, FACS efficiently eliminated islet endocrine and acinar cells, 
and enriched for a population of primary adult pancreatic duct cells that expanded as epithelial spheres 
in feeder- and serum-free culture.
Maintenance of ductal phenotypes by self-renewing human pancreatic 
CD133+ cells
After commencing in vitro cultures, the epithelial spheres from CD133+ ductal cells attained diameters 
ranging from 40 to 520 µm in 2 weeks (Figure 1A, Figure 1—figure supplement 1A and Figure 2—
figure supplement 1A). Spheres 350–500 µm in diameter were composed of 1470 ± 310 cells (n = 5); 
thus, based on evidence of clonal expansion (see below), we calculated that spheres resulted from a 
minimum of 10 cell divisions in 2 weeks. Sphere epithelium maintained KRT19 protein expression and 
a polarized monolayer as indicated by apical localization of CD133 (Figure 2A, Figure 2—figure 
supplement 1A,D). Neither acinar (CPA1) nor islet endocrine (CHGA and insulin C-peptide) markers 
were detectable (Figure 3C and data not shown), suggesting epithelial cells in cultured spheres 
maintained ductal characteristics.
Developmental biology and stem cells | Human biology and medicine
Lee et al. eLife 2013;2:e00940. DOI: 10.7554/eLife.00940 4 of 22
Research article
To assess whether sphere growth was achieved by cell proliferation or by other mechanisms like cell 
migration and aggregation, we analyzed spheres by immunostaining and time-lapse imaging. 
Immunohistochemistry revealed the proliferation marker Ki-67 in more than 25% of cells comprising 
2-week-old spheres (Figure 2A, Figure 2—figure supplement 1B; labeling index 26.5 ± 5.1%), data 
further supported by detection of a second proliferation marker, phospho-histone H3 (Figure 2A). 
Time-lapse imaging revealed that spheres arose from single cells (Figure 2B), providing strong 
evidence that sphere formation resulted from CD133+ ductal cell proliferation, rather than through cell 
migration and aggregation. Enzymatic dispersion of 2-week-old G1 spheres and subsequent culture 
Table 1. Phenotypes of pancreas donors
Anonymous ID Age (year) Gender Body mass index
1 31 Male 28.1
2 52 Male 31.6
3 52 Male Not provided
6 16 Female 20.4
9 34 Male 35.4
10 50 Female 23
11 32 Female 36.2
12 35 Male 45.7
13 23 Female 26.6
14 51 Female 23.3
15 48 Male 36.7
16 25 Male 21.8
17 63 Female 30.9
18 44 Male 24.7
19 39 Male 27.36
20 44 Male 23.5
21 50 Female 31
22 40 Female 26
23 53 Male 31
24 19 Female 20.83
25 34 Male 22.8
26 55 Male 37.7
27 17 Female 31.1
28 33 Male 18.8
29 48 Male 36.6
30 40 Female 28.4
31 43 Female 35.3
32 47 Female 21
33 48 Female 23.3
37 28 Male 24.2
40 34 Male 32.8
41 22 Male 19.6
42 53 Female 22.4
44 16 Male 33.9
45 54 Male 29.6
46 18 Male 21.8
48 24 Male 25.5
DOI: 10.7554/eLife.00940.003
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Figure 1. The ductal cell surface marker CD133 enriches sphere-forming cells from dissociated human adult 
pancreas. (A) Left panel, FACS plot of the dissociated human adult pancreas stained with (gray) or without (blue) 
antibodies specific for CD133. Right panel, A schematic of the sphere culture system and a representative sphere 
Figure 1. Continued on next page
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revealed that the spheres can be passaged up to seven generations (G7, 3 months) and that the total 
number of cells increased with each generation (Figure 2C,D, Figure 2—figure supplement 1C). 
After G7, ductal cell expansion was not achieved, and the spheres were not formed (Figure 2—figure 
supplement 1C and data not shown), supporting the view that ductal epithelial cells are not 
immortalized, and consistent with the origin of pancreatic cells from donors without neoplasia.
Neurog3 converts pancreatic duct cells into progeny expressing 
islet hormones
The endocrine potential of human or mouse pancreatic ductal cells remains controversial. To investi-
gate the potential of purified human pancreatic ductal cells to achieve an endocrine fate, we used an 
after culture. (B) Quantification of spheres generated from CD133+, CD133neg, and unsorted cells. Data are 
presented as mean ± SEM (n = 4). (C) Immunostaining of CD133 (green) with a ductal marker KRT19 (red) and 
C-peptide (red) in adult human pancreas. (D) The gene expression profiles of FACS-sorted human adult pancreatic 
cells and isolated islets (islet values normalized to 1). Data are presented as mean ± SEM (n = 3). (E) Representative 
immunostaining pictures of sorted cells with KRT19 (green) or C-peptide (green). (F) Quantification of cell 
immunostaining after FACS. ≥7200 cells were counted per staining condition. n.d.= not detected. Scale bars, 50 µm. 
See also Supplementary file 1D.
DOI: 10.7554/eLife.00940.004
The following figure supplements are available for figure 1:
Figure supplement 1. Sorted CD133+ cells originate from pancreatic ducts. 
DOI: 10.7554/eLife.00940.005
Figure 1. Continued
Figure 2. Clonal expansion and passaging of ductal spheres. (A) Confocal images of 2-week-old spheres immunostained with KRT19, CD133, Ki-67, and 
Phospho-Histone H3 (all green). Note the apical localization of CD133. Scale bars, 50 µm. (B) Representative time-lapse images of sphere formation from 
single cell (arrowhead). Images taken every 12 hr for 9 days are shown. Arrows point a non-sphere forming cell used as a landmark. (C) Representative 
pictures of spheres after each passage. Scale bars, 100 µm. (D) Quantification of cell number in spheres after each indicated passage. Y axis represents 
fold increase of total cell numbers relative to the one measured in the first ‘generation’ of spheres (G1).
DOI: 10.7554/eLife.00940.006
The following figure supplements are available for figure 2:
Figure supplement 1. Quantification of sphere growth and passaging. 
DOI: 10.7554/eLife.00940.007
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adenovirus-mediated transgenic system. Neurog3 is a transcription factor necessary and sufficient 
for pancreatic endocrine cell differentiation in vivo (Gradwohl et al., 2000; Gu et al., 2002) and, 
combined with other factors, can induce pancreatic acinar-to-islet cell conversion in mice (Zhou et al., 
2008). To test if Neurog3 expression could respecify human duct cells toward an endocrine fate, we 
infected cultured spheres as well as primary CD133+ cells with recombinant adenovirus co-expressing 
red fluorescent protein and Neurog3 (Ad-RFP-Neurog3), and assessed changes in gene expression by 
qRT-PCR (Figure 3A–C and 4C). Neurog3 induced the expression of NEUROD1, INSM1, and RFX6 
(Figure 3C), genes whose mouse homologs are known direct targets of Neurog3 in pancreas 
development (Mellitzer et al., 2006; Smith et al., 2010). Ad-RFP-Neurog3 infection induced ex-
pression of the pan-endocrine markers chromogranin A (CHGA) and synaptophysin in both primary 
CD133+ duct cells and cultured spheres (Figures 3C and 4C, and data not shown). Ad-RFP-Neurog3 
infection also induced expression of mRNA encoding PAX4 and NKX2.2, transcriptional regulators of 
pancreatic endocrine cell fate (Sosa-Pineda et al., 1997; Sussel et al., 1998), and mRNA encoding 
crucial β-cell factors such as the prohormone processing enzymes PCSK1 (PC1/3) and PCSK2 (PC2), 
KATP channel components KCNJ11 (KIR6.2) and ABCC8 (SUR1), and glucokinase (GCK) (Figure 4D). 
Moreover, Ad-RFP-Neurog3 significantly induced mRNA encoding the pancreatic hormones ghrelin 
and somatostatin, but not mRNAs encoding insulin, glucagon, PPY or the intestinal hormones 
cholecystokinin and gastrin (Figures 3C and 4D, Figure 4—figure supplement 1A, and data not shown). 
These findings support the conclusion that human adult pancreatic ductal cells harbor pancreatic 
endocrine potential upon induction of Neurog3.
Immunostaining confirmed these qRT-PCR findings and demonstrated that only RFP+ cells 
produced by Ad-RFP-Neurog3 infection were immunostained with antibodies recognizing NEUROD1, 
NKX2.2, CHGA, SST or GHRL (Figure 3B,D, Figure 3—figure supplement 1). We also confirmed that 
no insulin-, glucagon- or PPY-positive cells were observed by immunostaining (data not shown). While 
only a subset of cells infected with Ad-RFP-Neurog3 (RFP+) expressed CHGA, we noted all GHRL+ or 
SST+ cells co-expressed CHGA (Figure 3D). Quantification of CHGA+ and hormone+ cells revealed that 
30% of infected cells (RFP+) expressed CHGA. At least 45% of CHGA+ cells produced SST or GHRL, 
and less than 2% of CHGA+ cells expressed both hormones (Figure 3D,E). Thus, Neurog3 expression 
efficiently converted primary human ductal cells and cultured ductal epithelial spheres into hormone-
expressing cells with cardinal features of endocrine pancreas.
In mice, Neurog3 gene dosage can determine commitment between exocrine and endocrine 
lineages in pancreas development (Wang et al., 2010). Therefore, we next assessed the possibility 
that the 70% of RFP+ cells infected by Ad-RFP-Neurog3 failing to express CHGA may have achieved 
inadequate levels of Neurog3 expression. We fractionated cells produced by Ad-RFP-Neurog3 
infection by RFP intensity and measured mRNA expression of Neurog3, CHGA, SST and GHRL by 
qRT-PCR (Figure 3F,G). We found that cell fractions with the highest levels of RFP expression (‘P4 and P5’, 
Figure 3F) had the highest levels of mouse Neurog3 mRNA, and only these cell fractions produced 
mRNA encoding CHGA, SST or GHRL (Figure 3G). These data suggest that relatively high threshold 
levels of Neurog3 may be necessary and sufficient for directing endocrine differentiation of human 
pancreatic cells.
Conversion of pancreatic duct cells into progeny that produce, process, 
and store insulin
The transcription factors MafA, Neurog3, and Pdx1 (a combination hereafter summarized as ‘MNP’) 
were sufficient to convert adult mouse acinar cells into insulin-producing cells (IPCs: Zhou et al., 
2008). We constructed three adenoviruses expressing MafA, Neurog3, or Pdx1 (see ‘Materials and 
methods’; Figure 4A), and infected cultured spheres with this MNP combination. Within 5 days after 
infection, we reproducibly detected INS mRNA induction but at extremely low levels relative to adult 
human islet controls (0.0035 ± 0.0012% of islet levels; Figure 4B). Thus, we sought additional factors 
and discovered that mRNA encoding PAX6, an important regulator of mouse pancreatic endocrine cell 
development (Sander et al., 1997), was induced by MNP to only 0.03% of levels in control islets 
(Figure 4—figure supplement 1A). When combined with MafA, Neurog3, and Pdx1 (encoded in 
four viruses, ‘4V’), Pax6 induced INS expression in primary CD133+ ductal cells or spheres by over 
30-fold relative to MNP (Figure 4A,C,D). We observed ductal conversion to IPCs with four con-
secutive, independent donors (INS, Figure 4D). We also detected substantially increased expression 
of other islet endocrine markers, including SST, GCK, PCSK1, KCNJ11, and ABCC8 (Figure 4D). 
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Figure 3. Neurog3 is sufficient to convert pancreatic ductal spheres into hormone-expressing endocrine-like cells. 
(A) Schematic of growth and reprogramming strategies. See ‘Materials and methods’ for details. (B) Schematics of 
adenoviral constructs used. (C) Relative mRNA level of Neurog3 targets (NEUROD1, INSM1, and RFX6), endocrine 
cell-specific genes (PAX4, NKX2.2, and CHGA), and pancreatic hormones (SST and GHRL). Data are presented as 
Figure 3. Continued on next page
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Immunohistochemical analyses demonstrated that the number of Insulin+ cells was increased by 18 to 
20-fold in spheres transduced by the four factor combination (4V) compared to the MNP combination 
(Figure 4F,G). ELISA studies quantified and confirmed this increase of proinsulin levels, showing 
that the spheres derived from 4V exposure contained proinsulin levels that averaged 0.7% of those in 
human islets (Figure 5E). Systematic removal of individual factors from this four virus combination 
revealed that omission of Neurog3 prevented expression of INS, CHGA or SST (Figure 4E). Omission of 
virus expressing MafA or Pax6 from this combination significantly reduced INS expression (Figure 4E–G), 
whereas omission of virus expressing Pdx1 did not significantly decrease INS expression. Thus, 
Neurog3-mediated endocrine cell conversion is required for the production of IPCs as well as other 
hormone-producing cells from ductal spheres.
Although ELISA studies readily detected proinsulin production by IPCs in our 4V spheres, we failed 
to detect processed C-peptide by ELISA (Figure 5E) or by immunostaining with antibodies recognizing 
cleaved C-peptide (data not shown). Thus, we sought methods to enhance proinsulin processing 
in IPCs produced by genetic conversion. For this, we used Ad-Neurog3-IRES-eGFP and a second 
adenovirus constructed to express simultaneously the three transcription factors MAFA, PAX6, and 
PDX1 (Ad-eGFP-M6P) in cultured G1 spheres (Figure 5A, referred to as ‘4TF’ combination). Compared 
to our standard 5 day post-infection culture (4TF), we found that two additional weeks of culture 
(referred to as ‘4TFM’) resulted in a 10-fold increase of INS mRNA expression in spheres (Figure 5B,C, 
Figure 5—figure supplement 1A). We observed conversion to IPCs with five consecutive, inde-
pendent donors (INS, Figure 5C), demonstrating the robustness of our conversion method. The total 
number of converted IPCs appeared unchanged after this extended culture compared to 4V cultures 
(Figure 4G, Figure 5—figure supplement 1B), suggesting that INS mRNA levels per cell were 
increased in the 4TFM (4 transcription factors in two viruses plus maturation period) condition. In 
addition, mRNA encoding islet amyloid pancreatic polypeptide (IAPP), a β-cell dense core granule 
component not detectable in standard 4TF conditions, was readily detected in 4TFM spheres (Figure 5—
figure supplement 1A). Likewise, multiple mRNAs encoding β-cell factors were expressed at levels 
comparable to those in purified human islets (Figure 5C), including the transcription factors NKX2.2 
and NKX6.1, GCK, glucose transporters SLC2A1 (GLUT1) and SLC2A2 (GLUT2), PCSK1, PCSK2, 
Zinc transporter SLC30A8, KCNJ11, ABCC8, the voltage-gated calcium channel component 
CACNA1C, regulators of Ca++-induced insulin exocytosis like RAB3A, SYT3, and VAMP2, and the 
postulated maturation marker Urocortin 3 (UCN3) (Suckale and Solimena, 2010; Blum et al., 2012). 
Immunohistochemical analyses corroborated our qRT-PCR analysis, and showed that converted Insulin+ 
IPCs did not express other islet hormones (Figure 5D). Although we were unable to assess endogenous 
MAFA and PDX1 in cells with virally-expressed exogenous MAFA and PDX1 protein, we readily 
detected other known β-cell specific markers including NKX6.1, IAPP, and PC1/3 (Figure 5D). 
Moreover, Insulin+ cells, but not other hormone+ cells, expressed NKX6.1, a transcription factor with 
expression normally restricted in islets to β-cells (Figure 5—figure supplement 1C and data not 
shown).
To assess enhanced IPC maturation after extended culture (4TFM), we measured proinsulin and 
insulin C-peptide by ELISA. Total insulin (proinsulin + C-peptide) levels ranged from 3.4 to 15.2 pmol/µg 
DNA (Figure 5E), equal to approximately 9.6% of the total insulin protein level found in human adult 
islets (Figure 5E). Moreover, the percentage of insulin C-peptide processing in IPCs was comparable 
to that found in adult human islets (IPCs 77–92%; human islets 96–97%), indicating that maturation of 
mean ± SEM (n ≥ 3). (D) Representative confocal images of Ad-RFP-Neurog3 infected spheres after immunostaining 
with antibodies specific to mouse Neurog3, NEUROD1, NKX2.2, SST, and GHRL. Note that all hormone-positive 
cells are CHGA-positive. Right: co-staining of SST and GHRL. Scale bar, 20 µm. (E) Quantification of the staining 
results shown in (D). Pie graph represents the percentage of the hormone+ cells. (F) A representative FACS plot of 
dissociated ductal spheres infected with Ad-RFP-Neurog3 adenovirus (red) or uninfected control (gray). Fractions 
P1 through P5 were sorted based on RFP fluorescence intensity. (G) qRT-PCR analysis of fractions P1 through P5 
from (F). ‘U’ indicates unsorted cells. Analytical duplicates are shown. Data are presented as mean ± SD.
DOI: 10.7554/eLife.00940.008
The following figure supplements are available for figure 3:
Figure supplement 1. Representative confocal images of spheres infected with control virus (Ad-RFP). 
DOI: 10.7554/eLife.00940.009
Figure 3. Continued
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Figure 4. Induction of four transcription factors (Neurog3, MafA, Pdx1, and Pax6) produces Insulin+ endocrine cells 
in pancreatic ductal spheres in vitro. (A) Schematics of adenoviruses used. (B) INS qRT-PCR analysis of human 
spheres infected with control (R = RFP) or a combination of MafA (M), Neurog3 (N), and Pdx1 (P) (MNP) n = 4.  
Figure 4. Continued on next page
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IPCs during extended culture permitted proinsulin processing (Figure 5E). Ultrastructural studies by 
electron microscopy demonstrated round dense-core vesicles (Figure 5F) resembling those in adult 
human β-cells, including subsets of immature (light core) and mature (dense or crystallized core) 
vesicles, and vesicles adjacent to the plasma membrane (Figure 5F, Figure 5—figure supplement 1D). 
Consistent with the detection of SST mRNA (Figure 5C,D), we also observed rare cells with irregular 
electron-dense granules characteristic of islet δ-cells (Figure 5—figure supplement 1E; Klimstra 
et al., 2007).
Regulated insulin C-peptide secretion by IPCs
Native islet β-cells depolarize and secrete insulin and C-peptide in response to glucose and other 
physiological or pharmacological stimuli, but reconstructing these hallmark functions in progeny of 
purified primary human non-β-cells has not been previously achieved during in vitro culture. Compared 
to baseline secretion in media with 0.1 mM glucose, IPCs increased insulin C-peptide secretion by 
2.4-fold upon exposure to 2 mM glucose (Figure 5G). Similar to insulin release by human islet β-cells 
(Lupi et al., 1999), glucose stimulated the secretion of approximately 4% of total insulin C-peptide in 
IPCs (Figure 5—figure supplement 1G). This effect was blocked when the cells were incubated with 
glucose and Diazoxide, a drug that opens KATP channels and prevents glucose-stimulated insulin 
secretion (Figure 5G). However, unlike adult human islet β-cells, the release of insulin by IPCs was not 
further increased by 11 mM glucose. Islets from fetal or neonatal stages do not show elevated insulin 
secretion by high level glucose challenge (Rozzo et al., 2009), suggesting that IPCs are similar to 
immature islet β-cells and that further maturation is possible (Figure 5G). Calcium and voltage-
dependent calcium channels are important regulators of normal insulin secretion after KATP channel-
mediated membrane depolarization in β-cells (Henquin, 2005). When calcium was omitted in secretion 
buffer, C-peptide secretion stimulated by glucose was abolished, but restored upon calcium addition 
(Figure 5G). Insulin C-peptide release by cultured IPCs was also induced by the depolarizing agent 
potassium chloride (30 mM KCl), an effect reversed by a subsequent wash in media with 4.8 mM 
potassium ion (Figure 5G, figure 5—figure supplement 1H). Treatment with tolbutamide, a KATP 
channel blocker causing membrane depolarization, also stimulated insulin secretion by IPCs, an 
effect prevented by omission of calcium (Figure 5G). Together with data showing expression of key 
regulators of stimulus-secretion coupling, these findings provide strong evidence that IPCs produced 
by conversion and extended culture in our system develop regulated insulin secretion.
We examined the stability of the conversion of human ducts into IPCs by long-term transplantation of 
the converted spheres into specific transplantation sites of NOD scid gamma (NSG) mice (Figure 5—
figure supplement 2; Supplementary file 1A). Human C-peptide was readily detected in kidney 
grafts harvested at specific times by immunostaining (8/12 cases, Figure 5—figure supplement 2A; 
Supplementary file 1A) and by ELISA (9/10 cases, Supplementary file 1A) without detectable tumor 
formation. This also included C-peptide+ IPCs left in the transplant location beyond 5 months (Figure 5—
figure supplement 2A, d151), suggesting converted IPCs were stable. However, we observed that the 
total number of grafted C-peptide+ cells was drastically reduced within 2 weeks after transplantation, 
likely due to the apoptotic cell death. In three independent IPC transplants, however, we were 
able to detect circulating human insulin in the serum of host mice, and its level increased following 
(C) qRT-PCR analysis of INS, SST, and CHGA with freshly sorted CD133+ ductal cells infected with adenoviruses 
encoding Neurog3 or all four genes (4V) (n = 2). (D) qRT-PCR analysis of the spheres infected with a combination of 
adenoviruses. Pax6 abbreviated as ‘6’, (n ≥ 3). (E) qRT-PCR analysis of the spheres infected with 4V minus each 
indicated factor n = 2. All bar graph data are presented as mean ± SEM with mRNA levels from purified adult 
human islets normalized to 1. (F) Confocal images of infected spheres after staining with antibodies recognizing 
C-peptide. Note that adenoviruses encoding Neurog3 (N) and Pdx1 (P) also express RFP. Scale bar, 20 µm. 
(G) Quantification of the CHGA-, SST-, and C-peptide-immunoreactive cells in the spheres infected with the 
indicated combination of adenoviruses. Note that the number of C-peptide-positive cells increased in 4V than 
MNP by 18–20-fold.
DOI: 10.7554/eLife.00940.010
The following figure supplements are available for figure 4:
Figure supplement 1. GCG, PPY, and PAX6 mRNA levels after sphere infection with adenovirus combinations. 
DOI: 10.7554/eLife.00940.011
Figure 4. Continued
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Figure 5. Induced insulin-secreting cells resemble functional β-cells. (A) Schematic of adenoviral constructs used. 
See ‘Materials and methods’ and Figure 5—figure supplement 5 for details. (B) A schematic diagram of growth, 
conversion, and maturation procedures. (C) qRT-PCR analysis of spheres infected with Ad-eGFP (black) or 
Ad-4TF (gray) followed by extended culture. Data are normalized to adult human islet samples (red dotted line). 
Figure 5. Continued on next page
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intraperitoneal glucose challenge (Figure 5—figure supplement 2B; Supplementary file 1B). 
Therefore, these data suggest that despite extensive cell death in early stages of transplantation, IPCs 
can further mature in vivo and release increased levels of insulin in response to acute glucose challenge.
Discussion
Methods to regenerate lost or injured cells in diseases like diabetes mellitus are the focus of intensive 
investigations (McKnight et al., 2010; Benitez et al., 2012). Generation of insulin-producing cells 
from human stem cell lines like human ES cells (D’Amour et al., 2006; Kroon et al., 2008) is an 
important, and oft-cited ‘benchmark’, in efforts to achieve β-cell replacement. However, in these prior 
reports, progeny of human ES cells developed largely as poly-hormonal cells, most frequently 
expressing both glucagon and insulin. Moreover such hESC progeny failed to secrete insulin in 
response to glucose or other secretagogues unless transplanted as progenitors for >2 months in mice 
(Nostro and Keller, 2012). This transplant-based maturation strategy was complicated by tumor 
formation (Fujikawa et al., 2005). Thus, it has remained unknown whether human cells can develop 
solely in vitro to generate glucose-responsive insulin-secreting progeny without tumorigenicity. Our 
data indicate that in principal this can be achieved, using a small number of genes in sorted human 
pancreatic ductal cells that convert them toward an islet fate, including progeny that produce, store, 
and secrete insulin in response to glucose.
Conversion of mouse acinar cells into insulin-producing cells using adenoviral delivery of Neurog3, 
Pdx1, and MafA was previously reported (Zhou et al., 2008). However, it has remained unknown 
whether human pancreatic cells can be converted using transgenic methods toward a β-cell fate. We 
were unable to culture and expand primary human pancreatic acinar cells (Figure 1B and data not 
shown); moreover, we found that the combination of these three genes (MNP) was insufficient to 
reprogram primary or expanded human pancreatic ductal cells toward a β-cell fate, suggesting 
transgenic conversion may be restricted by species and cell type. Thus, we postulated that additional 
transcriptional regulators might be needed to promote human ductal conversion toward a β-cell fate. 
Like Neurog3, MafA, and Pdx1, the transcription factor Pax6 is expressed in both fetal and adult 
pancreas, and required to achieve appropriately high levels of Ins and Gcg expression in mouse islet 
cell development (Sander et al., 1997; Wang et al., 2009, 2010; Pan and Wright, 2011). Together 
with the other factors, we found that Pax6 significantly enhanced expression of β-cell markers during 
ductal reprogramming into β-cells, and was shown as an essential factor for this process. By systematic 
addition or omission of each transcription factor, we found PDX1 is not required for IPC formation. 
Thus, unlike mouse acinar cells (Zhou et al., 2008) and human hepatocytes (Sapir et al., 2005), human 
(D) Representative confocal images of 4TFM spheres immunostained with indicated antibodies. Scale bar, 20 µm. 
(E) Quantification of total proinsulin and C-peptide content in GFP, 4TF, 4TFM spheres and human adult islets (Top). 
Total protein level (pmol) was normalized by total genomic DNA content (µg). Ratio of proinsulin and C-peptide 
content is presented as % (Bottom). Sph. = Spheres. (F) Representative electron microscopic images of 4TFM 
spheres. Dotted white line demarks cell boundary between converted, granulated (left) and non-converted (right) 
cells. Dense core vesicles with different morphology in converted cells are shown in the right panels. Scale bar,  
1 µm. (G) Human C-peptide secretion assay of 4TFM spheres stimulated by the indicated secretagogues and 
drugs. Gluc = Glucose, Tol = Tolbutamide, Diaz. = Diazoxide. Data are presented as means ± SEM (n = 2 for Diaz.; 
n ≥ 3 for all other conditions).
DOI: 10.7554/eLife.00940.012
The following figure supplements are available for figure 5:
Figure supplement 1. Phenotypes of induced Insulin-secreting cells. 
DOI: 10.7554/eLife.00940.013
Figure supplement 2. Grafted IPCs survive long term and secrete insulin C-peptide upon glucose stimulation. 
DOI: 10.7554/eLife.00940.014
Figure supplement 3. Sustained expression of exogenous factors after maturation period. 
DOI: 10.7554/eLife.00940.015
Figure supplement 4. Conversion of human dermal fibroblasts. 
DOI: 10.7554/eLife.00940.016
Figure supplement 5. Protein expression of viral transgenes. 
DOI: 10.7554/eLife.00940.017
Figure 5. Continued
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ductal cells do not require exogenous Pdx1 expression for conversion toward an endocrine fate, for 
reasons that remain unclear. Our findings are also consistent with recent reports that transgenic adult 
mouse ductal cells can generate endocrine cells in vivo (Al-Hasani et al., 2013).
We initially attempted to induce spontaneous differentiation of pancreatic ductal cells using 
systematic variations of culture conditions, but these efforts proved unsuccessful (J Lee, unpublished 
results). During pancreas development, Neurog3 level surges in a subset of pancreatic progenitors 
located in primitive ducts, inducing development of endocrine cell fates (Zhou et al., 2007; Miyatsuka 
et al., 2009). Therefore, based on this model, we attempted to mimic induction of Neurog3 in human 
ductal cells using adenoviral overexpression of Neurog3. We found that Neurog3 was necessary and 
sufficient for reprogramming human ductal cells, and that the level of ectopic Neurog3 mRNA 
expressed in ductal cells correlated well with the extent of endocrine reprogramming, including 
expression of islet hormones (Figure 3G). These findings are reminiscent of studies by Gu et al. 
showing that reduced Neurog3 gene dosage in mice leads to respecification of pancreatic endocrine 
progenitors into ductal and acinar cells (Wang et al., 2010). Thus, Neurog3 functions may be evolu-
tionarily conserved in allocating cells toward an exocrine or endocrine fate (whether in development 
or experimental cell conversion) in a dosage-dependent manner. Consistent with prior work revealing 
that Neurog3 attenuates islet cell proliferation (Miyatsuka et al., 2011), we did not observe multiple 
rounds of cell division, an important prerequisite for some de-differentiation events (Hanna et al., 
2009), during Neurog3-dependent cell conversion. Also, we observed Neurog3 induction alone can 
rapidly upregulate endocrine molecular signatures in cultured human ductal cells. Thus endocrine cell 
conversion described here may involve direct conversion of human ductal cells into endocrine cells, 
rather than de-differentiation, but additional studies are required to assess this possibility. Our findings, 
albeit with enforced transcription factor expression in adult cells, indicate that Neurog3 expression is 
sufficient to induce latent endocrine programs in human adult ductal cells, a capacity not yet clearly 
demonstrated, to our knowledge.
We demonstrated robust expansion of purified human ductal cells in 3-dimensional culture. The 
cells were clonally expanded and serially passaged up to seven generations over 3 months, achieving 
an increase in cell number calculated to be up to 3,200-fold. By contrast, in prior studies, the maximum 
duration of sustained culture achieved with primary human pancreatic ductal cells was 5 weeks 
(Trautmann et al., 1993; Bonner-Weir et al., 2000; Rescan et al., 2005; Hao et al., 2006; Yatoh 
et al., 2007; Hoesli et al., 2012). Moreover, cultured cells in spheres maintained cardinal features of 
primary pancreatic ducts such as apical-basal polarity and KRT19 expression up to seven generations 
(Figure 2—figure supplement 1D,E). Thus, features of our culture system may be useful for studying 
the genetics and biology of human ductal cells.
Prior studies have reported that duct-containing fractions from human adult pancreas can form 
insulin-producing cells in vitro (Bonner-Weir et al., 2000; Hao et al., 2006; Heremans et al., 2002; 
Noguchi et al., 2006; Koblas et al., 2008; Swales et al., 2012) or after xeno-transplantion in mice 
(Yatoh et al., 2007). However, the possibility of endocrine cell contamination in the initial ductal fraction 
or feeder/stromal cells used for co-culture was raised by the detection of mRNAs encoding islet cell 
hormones and other endocrine markers in these and other studies (Heremans et al., 2002; Gao et al., 
2005). Therefore, it remained elusive whether human pancreatic ducts retained the potential to 
produce islet endocrine cells in adult. In this report, we used FACS to fractionate CD133+ ductal cells 
and used molecular and immunocytological studies to demonstrate complete elimination of cells 
expressing markers of differentiated endocrine cells (including islet hormones). Therefore, subsequent 
conversion of these cells into functional endocrine cells provided unequivocal evidence that endocrine 
cell-free human adult CD133+ ductal cell fraction can be converted into islet endocrine cells. 
Centroacinar cells are located at the junction of acini and tip of intercalated ducts (Cleveland et al., 
2012) and their properties remain poorly understood. These cells express CD133 (Immervoll et al., 
2008), raising the possibility that our fractionated CD133+ cells also include centroacinar cells. Based 
on their relative paucity in the pancreas, it is unlikely that centroacinar cells are the exclusive source of 
spheres within this CD133+ fraction, as more than 11% of CD133+ cells were capable of generating 
spheres (Figure 1B). However, because of difficulties performing lineage-tracing experiments with 
human samples, we cannot exclude the possibility that centroacinar cells may also contribute to the 
conversion into endocrine cell lineages.
While expression of Pax6 along with Neurog3, Pdx1 and MafA significantly enhanced expression of 
INS and other β-cell marker genes in converted ductal cells, this transcription factor combination alone 
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was not sufficient to generate mature IPCs. We found that extending the culture period for 2 weeks 
after viral infection led to maturation of several hallmark β-cell functions, including expression of key 
β-cell factors, significant increases of INS mRNA and protein levels, proinsulin processing, dense-core 
granule formation, and Insulin secretion in response to glucose or other depolarizing stimuli. We 
tested four distinct culture media with or without serum for this extended culture, and all media 
permitted maturation of these β-cell properties in IPCs (Figure 5—figure supplement 1F and see 
‘Materials and methods’), indicating that the duration of culture is a key variable for promoting β-cell 
maturation in vitro. After maturation, the spheres contained an average of 7% total insulin compared 
to human islet controls, and 7–11% of cells comprising these spheres produced insulin C-peptide. 
Thus, we calculate that each reprogrammed Insulin+ cell produced between 49 and 77% of insulin 
levels observed in native β-cell controls, a comparable level to the IPCs derived from human ES cells 
(D’Amour et al., 2006).
Is the capacity of human ductal cells to be converted toward endocrine islet fates unique? A prior 
study by Sapir et al. (2005) suggests that human hepatocytes may be induced to express insulin. 
However, the conversion toward an insulin-producing fate was comparatively poor; resulting cells 
produced about 10,000-fold lower insulin mRNA level than that of human islets, about 3–4 orders of 
magnitude lower than from conversion of pancreatic duct spheres. In addition, characteristic dense 
core vesicles in converted hepatocytes were not observed, indicating insufficient conversion towards 
β-cells. Here, we also assessed the endocrine potential of primary human dermal fibroblasts, cells 
successfully ‘reprogrammed’ toward many non-fibroblast fates, including induced pluripotent stem 
cells (Takahashi et al., 2007), but detected no clear evidence of conversion toward an endocrine or 
β-cell fate (Figure 5—figure supplement 4, see ‘Materials and methods’ for details). Thus, conversion 
of human adult duct spheres into cells that produce and secrete insulin is singularly robust. Moreover, 
unlike prior studies of human ES cells that have high variability among ES cell lines used (D’Amour 
et al., 2006; Kroon et al., 2008), we demonstrated conversion toward insulin+ fates by ductal cells 
from multiple unrelated donors, another feature of the robustness of our methods.
Expression of factors produced from viral transgenes persisted in Insulin+ cells for at least 5 months, 
evidenced by the GFP expression in transplanted insulin-producing cells (Figure 5—figure Supplement 
2A and 3). The transgenes delivered by adenovirus do not generally persist in dividing cells (Zhou 
et al., 2008). We speculate that cell cycle arrest in Insulin+ cells may be induced by Neurog3 (Miyatsuka 
et al., 2011), thereby preventing dilution of viral transgene-encoded factors. Thus, further studies 
are needed to investigate how persistent expression of conversion factors like Neurog3 affects 
maintenance and maturation of endocrine phenotypes in converted cells. Survival of transplanted 
insulin-secreting cells produced from ductal cells was poor, and reduced yields following transplantation 
of ductal cells precluded physiological studies in mouse models of diabetes. Promoting survival of 
transplanted insulin-secreting cells is a general problem for transplant-based islet replacement 
approaches. Thus, studies of factors that enhance survival of Insulin+ ductal cell progeny are an important 
current focus.
In conclusion, our study provides unique evidence that primary human cells can generate progeny 
that produce, store and secrete insulin in response to glucose or depolarizing agents, the hallmark 
features of pancreatic β-cells. We also show that human pancreatic exocrine cells, like in mice (Zhou 
et al., 2008), can be converted by transgenes toward an endocrine islet-like cell fate. We speculate 
that gene-based strategies like those described here may be combined with other methods, including 
culture modulation by growth factors and small molecules (Warren et al., 2010), to optimize endocrine 
differentiation or conversion of diverse cellular sources to advance cell replacement for diabetes. We 
speculate that our cell culture system may also serve as the foundation to investigate the genetics and 
pathogenesis of diverse human diseases rooted in pancreatic ductal cells, including pancreatitis, cystic 
fibrosis, and adenocarcinoma.
Materials and methods
Cell preparation
Institutional review board approval for research use of human tissue was obtained from the Stanford 
University School of Medicine. Human islet-depleted cell fractions were obtained with appropriate 
consent from healthy, non-diabetic organ donors deceased due to acute traumatic or anoxic death by 
overnight shipping from the following facilities: Division of Transplantation (Massachusetts General 
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Hospital, MA), UAB Islet Resource Facility (University of Alabama at Birmingham, AL), UCSF Diabetes 
Center (University of California, San Francisco, CA), Kidney/pancreas transplantation center (University 
of Pennsylvania, PA), Islet Core of the University of Pittsburgh (Pittsburgh, PA), and Human Islet Isolation 
Program (The Hospital of the University of Virginia, VA). Donor samples with the age range 16–63 years 
(mean 38.24 years) used for this study are listed in Table 1. On receipt, the cell fractions were washed 
with PBS and cultured with CMRL media (Mediatech, Inc, Manassas, VA) supplemented with 10% 
heat inactivated fetal bovine serum (FBS, HyClone, Logan, UT), 2 mM GlutaMax (Life Technologies, 
Grand Island, NY), 2 mM nicotinamide (prepared in PBS, Sigma, St.Louis, MO), and 100 U Penicillin 
and 100 µg Streptomycin (Pen/Strep, Life Technologies) in a non-coated culture dish at 25.5°C in 5% 
CO2 until use. For dissociation, the cell pellet was washed with PBS, trypsinized with 0.05% Trypsin-
EDTA solution (Life Technologies) for 5 min, and quenched with 5 vol of FACS buffer (10 mM EGTA, 
2% FBS in PBS). Cells were collected by centrifugation and further digested in 1 U/ml dispase solution 
(Life Technologies) containing 0.1 mg/ml DNaseI in PBS on a nutating mixer at 37°C for 30 min. PBS 
washing was performed after each enzymatic digestion step. After centrifugation, the cell pellet was 
resuspended in FACS buffer and passed through a 40-µm-cell strainer. Cell viability and number were 
assessed using a Vi-Cell analyzer (Beckman Coulter, Fullerton, CA) and the samples exceeding 70% cell 
viability were used for subsequent antibody staining for FACS.
Cell sorting and culture
Dissociated cells were stained with biotin-conjugated CD133 antibodies (clone AC133 and 293C3, 
Miltenyi Biotec, Auburn, CA) and then Allophycocyanin-conjugated Streptavidin (eBioscience, San 
Diego, CA) for 15 min, each at room temperature. Cell pellets were collected by centrifugation and 
washed with PBS after each staining steps. Propidium Iodide (Life Technologies) staining was used 
to exclude dead cells. The cells were sorted using a FACSAria II (BD Biosciences, Bedford, MA) and 
collected in 100% FBS, washed with PBS twice, and resuspended in ice-cold Advanced DMEM/F-12 
media (Life Technologies) at a density of 8000 cells/µl. The average percentage of CD133+ fraction was 
32.73% (n = 32). 50 µl of growth factor-reduced Matrigel (BD Biosciences) was then added to 30 µl cell 
suspension and the mixture was placed around the bottom rim of each well. After solidification at 37°C 
for 60 min, each well was overlaid with 500 µl of modified crypt culture media (Sato et al., 2009) 
comprised of Advanced DMEM/F-12 media supplemented with recombinant human (rh) EGF (50 ng/ml, 
Sigma), rhR-spondin I (500 ng/ml, R&D systems, Minneapolis, MN), rhFGF10 (50 ng/ml, R&D systems), 
recombinant mouse Noggin (100 ng/ml, R&D systems), 10 mM Nicotinamide in PBS, and Pen/Strep. 
The media was changed twice weekly. The spheres were harvested after 2 to 3 weeks for passaging or 
viral infection. Static and time-lapse images of sphere growth were collected using Zeiss Axiovert 200 
inverted microscope and Zeiss Observer.Z1 equipped with a temperature- and CO2-controlled 
chamber using Axiovision (Carl Zeiss, Germany) and MetaMorph (Molecular Devices, Sunnyvale, CA) 
softwares, respectively. For harvesting spheres, 500 µl of 2 U/ml dispase (Life Technologies) solution 
containing 0.1 mg/ml DNaseI in PBS was added in each well and the Matrigel was mechanically 
disrupted by pipetting and incubated at 37°C for 45 min. The released spheres were collected, washed 
twice with PBS and used for subsequent applications. For passaging spheres, the harvested spheres 
were trypsinized at 37°C for 5 min followed by quenching with FBS. The dispersed cells were then 
used for cell counting with a hemocytometer or were plated as described above.
Construction of adenoviral vectors
Ad-eGFP and Ad-RFP control adenoviruses were purchased from Vector Biolabs (Philadelphia, PA). 
Ad-MafA and Ad-Neurog3-IRES-eGFP were described previously (Tashiro et al., 1999). To construct 
Ad-RFP-Neurog3 and Ad-RFP-Pdx1 adenoviruses, mouse cDNAs for Neurog3 (BC104326) and Pdx1 
(BC103581) were purchased from Open Biosystems (Lafayette, CO) and the inserts were obtained by 
restriction enzyme digestion with EcoR V/BamH I and EcoR V/Msc I, respectively. The inserts were then 
subcloned into multiple cloning sites of Dual-RFP-CCM shuttle vector (Vector Biolabs) and adenoviruses 
were constructed by Vector Biolabs. For Ad-eGFP-M6P, human MAFA cDNA (gift from M German), 
PDX1 (NM_000209; GeneCopoeia, Rockville, MD), and PAX6 (BC011953; Open Biosystems) were 
used for PCR amplification with the primers shown in Supplementary file 1C to add T2A, P2A, restric-
tion enzyme sites, and/or tagging proteins (Figure 5—figure supplement 5). A fused construct of 
MAFA-T2A-PAX6 was generated by PCR with MAFA and PAX6 PCR amplicons as templates. Similarly, 
PCR products for PAX6 and PDX1 were used to construct PAX6-P2A-PDX1. Next, MAFA-T2A-PAX6, 
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PAX6-P2A-PDX1, and pDual-GFP-CCM vector (Vector Biolabs) were cut with BglII/PstI, PstI/EcoRI, and 
BglII/EcoRI, respectively, and ligated with NEB quick ligation kit (New England Biolabs, Ipswich, MA) 
followed by transformation of TOP10 chemically competent cells (Invitrogen, Carlsbad, CA). The 
construct was then used for generating adenoviruses by Vector Biolabs.
Sphere infection and post-infection culture
Spheres were infected at 37°C in suspension overnight at a multiplicity of infection (MOI) 100 for 
Ad-MafA and Ad-eGFP-M6P, or MOI 500 for the rest of viruses used. The spheres were then washed 
twice with culture medium and embedded in Matrigel as described above. The infected spheres were 
overlayed with sphere growth media without R-spondin I and with 0.33 µM all-trans retinoic acid 
(Sigma), and cultured for 5 days. For extended culture, the media was replaced with either (1) DMEM 
with high glucose (Life Technologies) supplemented with 10% FBS (Hyclone) and Pen/Strep (Life 
Technologies) for 2 weeks (referred as ‘DF’ in Figure 3—figure supplement 1F), (2) DF plus 20 mM 
KCl and 10 µM R0-28-1675 (glucokinase activator; Axon Ligands) for 2 weeks (referred as ‘DFK’), 
(3) DF for one week and then DMEM/F-12 media (Life Technologies) supplemented with 0.5 × N2 
supplement (Life technologies), 0.5 × B27 (Life technologies), 0.2% BSA (Sigma), 1% ITS supplement 
(Life Technologies), 10 mM nicotinamide, 10 ng/ml recombinant human basic FGF (R&D systems), 
50 ng/ml Exendin-4 (R&D systems), recombinant human BMP-4 (R&D systems) for additional 1 week 
(referred as ‘Z’; Zhang et al., 2009), or (4) DMEM high glucose supplemented with 1 × B27, 55 nM 
GLP-1, 50 ng FGF10 (R&D Systems), and Pen/Strep for 3 days followed by 5 days with DMEM high 
glucose supplemented with 1 × B27, 55 nM GLP-1 (Sigma), 10 µM DAPT (Sigma), and Pen/Strep, then 
for 6 days with CMRL1066 media (Mediatech) supplemented with 1 × B27, 55 nM GLP-1, 50 ng HGF 
(R&D Systems), 50 ng IGF-1 (R&D Systems), and Pen/Strep (referred as ‘T’; Thatava et al., 2011). The 
media was replaced every other day unless otherwise noted.
cDNA preparation and qRT-PCR analyses
Total RNA was prepared from sorted cells or cultured spheres with QIAGEN RNeasy micro kit (QIAGEN 
Sciences, MD), and used for cDNA synthesis using QIAGEN Omniscript RT kit (QIAGEN), according 
to the manufacturer’s protocol. Relative mRNA level was measured by qRT-PCR of each cDNA in 
duplicate with gene-specific probe sets (Applied Biosystems, Foster City, CA) with TaqMan Universal 
PCR Master Mix (Applied Biosystems) and the ABI Prism 7500 detection system (Applied Biosystems). 
Normalizations across samples were performed using β-actin primers. Information of the primer and 
probe sets is available upon request.
Immunohistochemistry
For immunohistochemical analyses, cultured spheres were harvested, washed with PBS, mixed with 
20 µl of Collagen Gel Kit (Nitta Gelatin, Osaka, Japan), solidified at 37°C for 1 hr, fixed with 4% para-
formaldehyde for 2 hr at 4°C, cryoprotected in 30% sucrose solution in PBS overnight, embedded in 
OCT on dry ice, and sectioned in 8 µm thickness. For sorted cells, the cell suspension was washed once 
and resuspended with 20 µl of PBS, placed on a Polysine slide (Thermo scientific, Waltham, MA), and 
waited for 30 min at room temperature (RT) to let the cells sit on the slide glass by gravity. Then the 
solution was removed carefully and 40 µl of 4% paraformaldehyde was added. After 10 min of incubation 
at RT, the fixative was removed and the slides were washed with PBS three times for 5 min each. After 
removal of PBS, the slides were dried at RT for 1 hr and stored at −20°C. For immunostaining transplanted 
IPCs, grafted organs (kidney, EFP, or liver) were harvested, fixed with 4% paraformaldehyde overnight 
at 4°C, cryoprotected in 30% sucrose solution in PBS overnight, embedded in OCT on dry ice, and 
sectioned in 8 µm (kidney and liver) or 40 µm (EFP) thickness. The primary antibodies used were rabbit 
anti-Amylase (1:1000; Sigma), goat anti-Amylase (sc-12821; 1:200; Santa Cruz Biotechnology, Dallas, 
TX), CD133 (1:100 each; clone AC133 and 293C3; Miltenyi Biotec, Auburn, CA), rabbit anti-Chrom-
ograninA (20085; 1:100; Immunostar, Hudson, WI), mouse anti-ChromograninA (LK2H10; 1:200; Cell 
Marque, Rocklin, CA), mouse anti-CK19 (KRT19) (M0888; 1:200; DAKO, Carpinteria, CA), rabbit anti-
CK19 (319R-15; 1:200; Cell Marque), rabbit anti-CPA1 (1810-0006; 1:100; AbD Serotec, UK), rabbit 
anti-C-peptide (#4593B; 1:200; Cell Signaling Technology, Danvers, MA), mouse anti-C-peptide (capt) 
(1:100; Mercodia, Sweden), mouse anti-Flag (F1804; 1:1000; Sigma), goat anti-GHRL (sc-10368; 1:200; 
Santa Cruz Biotechnology), guinea pig anti-Glucagon (4031-01; 1:200; Linco, Billerica, MA), mouse 
anti-HA (MMS-101P-1000; 1:1000; Covance), mouse anti-HuNu (MAB1281; 1:200; Millipore, Billerica, 
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MA), mouse anti-IAPP (MCA1126T; 1:200; AbD serotec), rabbit anti-Ki-67 (NCL-Ki67p; 1:100, Leica 
Microsystems, Germany), rabbit anti-Myc (sc-789; 1:1000; Santa Cruz Biotechnology), mouse anti-
NeuroD (sc-46684; 1:10; Santa Cruz Biotechnology), mouse anti-Neurog3 (F25A1B3; 1:4000; DSHB, 
Iowa City, IA), mouse anti-Nkx2.2 (74.5A5; 1:10; DSHB), mouse anti-Nkx6.1 (F55A10; 1:200; DSHB), 
rabbit anti-PC1/3 (PCSK1, AB10553; 1:200; Millipore), rabbit anti-phospho-H3 (06-570; 1:500; 
Millipore), goat anti-PPY (NB100-1793; 1:200; Novus Biologicals, Littleton, CO), rabbit anti-Somatostatin 
(1:200, DAKO), goat anti-Somatostatin (sc-7819; 1:200; Santa Cruz Biotechnology), goat anti-SUR-1 
(sc-5789; 1:50; Santa Cruz Biotechnology). Tyramide signal amplification (Perkin Elmer, Waltham, MA) 
was used for antibodies against Neurog3, NeuroD, Nkx2.2, Nkx6.1, and PC1/3. Antigen unmasking 
(H-3300; Antigen Unmasking Solution, Citric Acid Based, Vector Laboratories, Burlingame, CA) was 
performed for anti-Flag antibody staining. The Neurog3, Nkx2.2, and Nkx6.1 antibodies developed by 
Dr OD Madsen were obtained from the Developmental Studies Hybridoma Bank (DSHB) developed 
under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological 
Sciences, Iowa City, IA 52242. Secondary antibodies used were from Jackson ImmunoResearch (West 
Grove, PA) or Molecular Probes (Eugene, OR). Stained sections were mounted with VECTASHIELD 
Mounting Medium with DAPI (Vector Laboratories). Fluorescence images were taken using Zeiss 
Axio Imager.M1 or Leica SP2 inverted confocal laser scanning microscope.
Electron microscopy
The samples were fixed in Karnovsky’s fixative: 2% Glutaraldehyde (EMS Cat# 16000) and 4% 
Paraformaldehyde (EMS; Electron Microscopy Sciences, Hatfield, PA) in 0.1 M Sodium Cacodylate (EMS) 
pH 7.4 for 1 hr at RT then cut, post fixed in 1% Osmium tetroxide (EMS) for 1 hr at RT, washed three times 
with ultrafiltered water, then en bloc stained for 2 hr at RT or moved to 4°C overnight. The samples were 
then dehydrated in a series of ethanol washes for 15 min each at 4°C beginning at 50%, 70%, 95%, where 
the samples are then allowed to rise to RT, changed to 100% two times, followed by Acetonitrile for 15 
min. The samples are infiltrated with EMbed-812 resin (EMS) mixed 1:1 with Acetonitrile for 2 hr followed 
by two parts EMbed-812 to 1 part Acetonitrile for 2 hr. The samples were then placed into EMbed-812 
for 2 hr and then placed into molds, and resin filled gelatin capsules with labels were orientated over 
the cells of interest and placed into 65°C oven overnight. Sections were taken between 75 and 90 nm 
on a Leica Ultracut S (Leica, Wetzlar, Germany), picked up on formvar/Carbon coated slot grids (EMS 
Cat#FCF2010-Cu) or 100 mesh Cu grids (EMS). Grids were contrast stained for 15 min in 1:1 saturated 
UrAcetate (∼7.7%) to 100% ethanol followed by staining in 0.2% lead citrate for 3 to 4 min. JEOL JEM-1400 
TEM was used to observe at 120 kV and photos were taken using a Gatan Orius digital camera.
C-peptide secretion and content measurement
C-peptide secretion assay and content measurement were performed as described previously with 
minor modification (Chen et al., 2001). Briefly for secretion assay, media was replaced a day before 
assay was performed. On the day, each well with matrigel-embedded spheres was incubated with 
fresh media for 2 hr, washed twice with plain Krebs-Ringer bicarbonate buffer (KRBB), and incubated 
twice with plain KRBB for 1 hr each for thorough washing. Next, the spheres were incubated consecu-
tively with 400 µl KRBB containing indicated concentrations of glucose (Sigma) with or without 0.5 mM 
Diazoxide (Sigma), KCl (30 mM, Sigma), or Tolbutamide (0.2 mM, Sigma) for 2 hr each. KRBB without 
Calcium (No Ca++) was prepared by omission of CaCl2 and addition of 1 mM EGTA (Sigma). Secreted 
C-peptide level was measured with Human Ultrasensitive C-peptide ELISA kit (Mercodia). For 
C-peptide content measurement, the spheres were harvested in 1.5 ml microfuge tube, washed with 
PBS, resuspended with 300 µl of ice-cold TE/BSA buffer (10 mM Tris-HCl, 1 mM EDTA, 0.1% wt/vol 
BSA, pH 7.0), and sonicated with Bioruptor Sonicator (Diagenode, Denville, NJ). Half of the lysate 
was used for genomic DNA isolation and quantification with Quant-iT PicoGreen dsDNA Assay Kit 
(Invitrogen). Same volume of acid alcohol (75% vol/vol ethanol, 2% vol/vol concentrated HCl, 23% 
vol/vol H2O) was added to the rest of lysate to extract C-peptide by rocking overnight at 4°C. The 
extract was then neutralized with 10 vol of PBS and used for C-peptide ELISA.
Transplantation
Transplantation in kidney capsule, epididymal fat pad (EFP), or in the liver by portal vein injection was 
performed as previously described (Kroon et al., 2008; Alipio et al., 2010; Wang et al., 2011). For 
transplantation in kidney or EFP, converted spheres with or without extended culture were harvested 
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and mixed with or without mouse embryonic fibroblasts (Supplementary file 1A). The spheres were 
then mixed with matrigel to make a final volume of 10 µl for kidney transplantation or overlayed on 
pre-wet gelfoam for EFP transplantation. For liver transplantation, single cells produced by trypsiniza-
tion of harvested spheres were resuspended in 100 µl PBS and injected into the portal vein with a 
27 G needle. All animal experiments and methods were approved by the Institutional Animal Care and 
Use Committee (IACUC) of Stanford University.
In vivo glucose-stimulated insulin secretion assay
Secretion of human Insulin or C-peptide by glucose injection was measured as previously described 
(Kroon et al., 2008). Briefly, transplanted mice were fasted overnight (14–16 hr) and 120 µl of blood was 
collected from tail into Microvette CB300LH (Sarstedt, Germany) to prepare 50 µl of serum. 3 g/kg glucose 
was then injected and blood was collected again 30 min after glucose administration. Secreted C-peptide 
or insulin level was measured with Human Ultrasensitive C-peptide or Insulin ELISA kits (Mercodia).
Human adult dermal fibroblast culture and conversion assay
Human adult dermal fibroblasts (Coriell Institute for Medical Research, Camden, New Jersey, USA) 
were cultured and maintained as described previously (Yoo et al., 2011). The cells were either 
trypsinized for suspension infection (as was described above for ductal spheres) or infected as 
adherent cells in six-well plates by direct addition of virus into the culture medium, with Ad-eGFP 
(GFP) or Ad-eGFP-M6P and Ad-Neurog3-IRES-eGFP (4TFM). The same MOIs used for ductal sphere 
infection were also used. The suspension-infected cells were harvested the following day and embedded 
in Matrigel as described above for infected ductal spheres. The culture was maintained for additional 
18 days to match the duration of infected ductal sphere maturation. The infected adherent cells were 
cultured with virus for 48 hr and the media was replaced. The culture was maintained for additional 
10 days, passaged in 1:3 ratio due to confluency, re-plated, and cultured additional 7 days to match 
the duration of infected ductal sphere maturation. In both cases, media was replaced every other day. 
Three independent experiments were performed for both conditions and each experiment at least in 
duplicates. RNA isolation, cDNA preparation, and qRT-PCR were performed with primers specific to 
human INS, CHGA, and β-actin as described above.
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